Southan G J, Salzman A L, Szabo C
Children's Hospital Medical Center, Division of Critical Care, Cincinnati, Ohio 45229, USA.
Life Sci. 1996;58(14):1139-48. doi: 10.1016/0024-3205(96)00072-0.
The generation of nitric oxide (NO) by nitric oxide synthase (NOS) can be inhibited by certain guanidines and S-alkylisothioureas. In particular, aminoethylisothiourea (AE-TU) shows selectivity towards the inducible isoform (iNOS) over the endothelial isoform (ecNOS). Here we report on the effects of the selenium analog of AE-TU, aminoethylisoselenourea (AE-SeU), and its homologue, aminopropylisoselenourea (AP-SeU), on the activities of iNOS and ecNOS. AE-SeU and AP-SeU inhibited the conversion of L-arginine to L-citrulline in homogenates of lung taken from endotoxin-treated rats (a model of iNOS acitivity) with potencies (EC50=1.1, and 0.1 microM, respectively) greater than that of N(G)-methyl-L-arginine (L-NMA) (22 microM). In contrast, AE-SeU and AP-SeU were weaker than or similar to L-NMA at inhibiting ecNOS activity in homogenized bovine endothelial cells (EC50 values = 104, 15, and 16 microM, respectively). AE-SeU and AP-SeU potently inhibited nitrite formation by immunostimulated J774 macrophages (a model of iNOS activity) with EC50 values of 10 and 4 microM respectively. The corresponding EC50 value for L-NMA was 160 microM. The inhibition was dose-dependently reduced by increasing concentrations of L-arginine in the medium. In vivo, AE-SeU had only modest effects on blood pressure when given as a bolus to anesthetized rats, suggesting only a small effect on ecNOS in vivo, whereas AP-SeU had potent pressor effects similar to those of L-NMA. We found that both AE-SeU and AP-SeU were unstable in aqueous solution at pH values above 6. Their disappearance from solution was accompanied by the appearance of a reductive species, probably free selenol. These findings suggest that AE-SeU and AP-SeU exert their inhibitory effects through intramolecular rearrangement to yield selenoethylguanidine and seleno-propylguanidine. Thus, selenoalkylguanidines are novel inhibitors of iNOS.
一氧化氮合酶(NOS)生成一氧化氮(NO)的过程可被某些胍类化合物和S-烷基异硫脲所抑制。特别是,氨基乙基异硫脲(AE-TU)对诱导型同工型(iNOS)的选择性高于内皮型同工型(ecNOS)。在此,我们报告了AE-TU的硒类似物氨基乙基异硒脲(AE-SeU)及其同系物氨基丙基异硒脲(AP-SeU)对iNOS和ecNOS活性的影响。AE-SeU和AP-SeU抑制了内毒素处理大鼠肺匀浆(iNOS活性模型)中L-精氨酸向L-瓜氨酸的转化,其效力(EC50分别为1.1和0.1 microM)高于N(G)-甲基-L-精氨酸(L-NMA)(22 microM)。相比之下,在匀浆的牛内皮细胞中,AE-SeU和AP-SeU抑制ecNOS活性的能力比L-NMA弱或与之相似(EC50值分别为104、15和16 microM)。AE-SeU和AP-SeU有效抑制免疫刺激的J774巨噬细胞(iNOS活性模型)产生亚硝酸盐,EC50值分别为10和4 microM。L-NMA的相应EC50值为160 microM。通过增加培养基中L-精氨酸的浓度,抑制作用呈剂量依赖性降低。在体内,给麻醉大鼠静脉注射AE-SeU时,其对血压的影响较小,表明其对体内ecNOS的影响较小,而AP-SeU具有与L-NMA相似的强效升压作用。我们发现,AE-SeU和AP-SeU在pH值高于6的水溶液中均不稳定。它们从溶液中消失的同时伴随着一种还原物质的出现,可能是游离硒醇。这些发现表明,AE-SeU和AP-SeU通过分子内重排产生硒代乙基胍和硒代丙基胍来发挥其抑制作用。因此,硒代烷基胍是iNOS的新型抑制剂。